. (2017). A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age. Vaccine, 35(30), 3749-3759. https://doi.org/10.1016/j.vaccine.2017.05.045 (Original work published 2017)
